Insider Transactions in Q1 2022 at Aerie Pharmaceuticals Inc (AERI)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2022
|
Peter Frederick Lang Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,297
+50.0%
|
-
|
|
Mar 18
2022
|
John La Rocca General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
19,015
+25.92%
|
-
|
|
Mar 18
2022
|
Casey C. Kopczynski Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,015
+6.35%
|
-
|
|
Feb 28
2022
|
Benjamin F Mcgraw Iii Director |
SELL
Payment of exercise price or tax liability
|
Direct |
10,324
-22.41%
|
$82,592
$8.3 P/Share
|
|
Feb 19
2022
|
John La Rocca General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,973
-5.29%
|
$11,838
$6.0 P/Share
|
|
Feb 08
2022
|
Thomas A Mitro President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,111
-1.35%
|
$7,777
$7.33 P/Share
|
|
Feb 08
2022
|
Casey C. Kopczynski Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
700
-0.27%
|
$4,900
$7.33 P/Share
|
|
Feb 07
2022
|
Thomas A Mitro President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,310
-1.56%
|
$9,170
$7.24 P/Share
|
|
Feb 07
2022
|
John La Rocca General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
768
-2.02%
|
$5,376
$7.24 P/Share
|
|
Feb 07
2022
|
Casey C. Kopczynski Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
701
-0.27%
|
$4,907
$7.24 P/Share
|
|
Feb 06
2022
|
Thomas A Mitro President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,435
-1.68%
|
$10,045
$7.05 P/Share
|
|
Feb 06
2022
|
John La Rocca General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
384
-1.0%
|
$2,688
$7.05 P/Share
|
|
Feb 06
2022
|
Casey C. Kopczynski Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
876
-0.33%
|
$6,132
$7.05 P/Share
|
|
Feb 04
2022
|
Thomas A Mitro President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,435
-1.66%
|
$10,045
$7.05 P/Share
|
|
Feb 04
2022
|
John La Rocca General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,206
-3.04%
|
$8,442
$7.05 P/Share
|
|
Feb 04
2022
|
Casey C. Kopczynski Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
963
-0.36%
|
$6,741
$7.05 P/Share
|
|
Feb 04
2022
|
David Hollander Chief R&D Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
927
-2.93%
|
$6,489
$7.05 P/Share
|
|
Jan 30
2022
|
Kathleen Mcginley CHRO & VP, Corp Services |
SELL
Payment of exercise price or tax liability
|
Direct |
878
-3.53%
|
$5,268
$6.92 P/Share
|